Fundraising Fox
Immventionthera
Chapel Hill, US · Founded 2017 · 14 employees on LinkedIn · 4 known investors
Find your way into Immventionthera
Sign up to find every way you can get introduced to Immventionthera
- Your email: who you already know at Immventionthera, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Immventionthera team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions. The biotech company is working in collaboration with Novo Nordisk.
Founders & leadership
Immventionthera was founded in 2017 by Jenny Ting.
Investors · 4
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $277.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Immventionthera do?
- Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions. The biotech company is working in collaboration with Novo Nordisk.
- Who founded Immventionthera?
- Immventionthera was founded by Jenny Ting in 2017.
- Who are Immventionthera's investors?
- Immventionthera's investors include Delin Ventures, Hatteras Venture Partners, Osage University Partners, OUP (Osage University Partners).
- Where is Immventionthera headquartered?
- Immventionthera is headquartered in Chapel Hill, US.